Blackmores CEO & MD Richard Henfrey resigns
Listed complementary medicines company Blackmores had announced the resignation of its CEO and MD Richard Henfrey.
Henfrey joined Blackmores in Apr 2009 and performed a number of key executive roles before being appointed CEO on 17 Aug 2017.
The company has confirmed Henfrey will remain in his current positions while the Board undertakes the search for its new CEO.
Chairman Brent Wallace said, “I would like to thank Richard for his service and leadership of the Group over the last 18 months and for his strong commitment to Blackmores, the industry and our stakeholders over his decade long tenure.
“He has played a pivotal role in the growth of Blackmores and in the industry of complementary medicine overall,” Wallace added.
“I am confident Richard will lead the transition period well, backed by our strong executive management team.”
See more in tomorrow’s Pharmacy Daily.
